fb tracking

Product Recalls: March 16, 2022 – April 13, 2022

Health Letter, May 2022

Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.


Meclizine hydrochloride tablets, 12.5 mg, packaged in a case of 24 bottles (100-count bottles). Manufactured by: Jubilant Cadista Pharmaceuticals, Inc. Lot # 22P0036, exp. date: 12/2024.


Accuretic (quinapril HCl/hydrochlorothiazide) tablets; 10 mg/12.5 mg, 20 mg/12.5 mg or 20 mg/25 mg; 90-tablet bottles. Distributed by: Parke-Davis, Division of Pfizer Inc. Lot #: FG5379, exp. date: 08/2024; Lot #: EA6686, exp. date: 04/2022; Lot #: EA6665, exp. date: 04/2022; Lot #: CN0640, exp. date: 04/2022; Lot #: ET6974, exp. date: 02/2023; Lot#: FG5381, exp. date: 08/2024.

Alprazolam tablets, 1 mg, 180-count bottles. Manufactured by ULTRAlab Laboratories, Inc. Lot #: GS027852, exp. date: 06/2022.

Glycopyrrolate tablets, 1 mg, 100-count bottle. Distributed by: Aurobindo Pharma USA, Inc. Lot #: 01421008A1, exp. date: 03/2023.

Hydralazine HCl tablets, 10 mg, 100 tablets per carton (10×10 blister packs). Distributed by: MAJOR PHARMACEUTICALS. Lot #: T03755 or T03756, exp. date: 03/2023; Lot #: GS027852, exp. date: 06/2022.

Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton. Sample-Not For Sale. Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Lot #: U015824, exp. date: 09/22.

Lansoprazole delayed-release capsules, 15 or 30 mg, 30- or 90-count bottle. Manufactured by: Dr. Reddy’s Laboratories Limited. Lot #: C2103093, exp. date: 12/2023; Lot #: C2103092, exp. date: 12/2023; Lot #: C2102911, exp. date: 12/2023.

Orphenadrine citrate extended-release tablets, 100 mg, 100 tablets. Manufactured by: Sandoz Inc. Lot #: JX6411 or JX6413, exp. date: 05/2022; Lot #: KC0723 or KC3303, exp. date: 08/2022; Lot #: KE4348, KE7169 or KE4349, exp. date: 11/2022; Lot #: KL3199, KM0072 or KS3939, exp. date: 03/2023; Lot #: LA7704, LA7703 or LA9243, exp. date: 11/2023.

Quinapril and hydrochlorothiazide tablets, 20 mg/25 mg or 20 mg/12.5 mg, 90-tablet bottles. Distributed by: Greenstone, LLC. Lot #: FE3714, exp. date: 02/2023; Lot #: DN6931, ED3904 or ED3905, exp. date: 03/2023; Lot #: DP3414, exp. date: 02/2023.

For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.


For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.